OSMT - Osmotica Pharmaceuticals plc (OSMT) CEO Brian Markison on Q2 2021 Results - Earnings Call Transcript

Osmotica Pharmaceuticals plc (OSMT) Q2 2021 Earnings Conference Call August 16, 2021 04:30 AM ET Company Participants Lisa Wilson - Investor Relations Brian Markison - Chief Executive Officer Andrew Einhorn - Chief Financial Officer JD Schaub - Chief Operating Officer Conference Call Participants David Steinberg - Jefferies Greg Fraser - Truist Securities Daniel Busby - RBC Capital Markets Presentation Operator Thank you for standing by and welcome to the Osmotica Pharmaceuticals' Second Quarter 2021 Business Update. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator Instructions] As a reminder, today's conference call is being recorded. I would now like to turn the conference to your host Ms. Lisa Wilson of Investor Relations. You may begin. Lisa Wilson Thank you operator. Welcome to Osmotica Pharmaceuticals' second quarter 2021 business update call. This is Lisa Wilson, Investor Relations for Osmotica.

For further details see:

Osmotica Pharmaceuticals plc (OSMT) CEO Brian Markison on Q2 2021 Results - Earnings Call Transcript